Skip to content

Author

Shabana Khatoon

We have 1 of 20 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Aug 2026

FAK and PYK2 as Central Resistance Nodes in Non-Small Cell Lung Cancer: Signalling Crosstalk and Combination Therapeutic Strategies

Although FAK/PYK2-targeted monotherapy has demonstrated limited clinical efficacy, rational combination strategies involving EGFR tyrosine kinase inhibitors, MAPK inhibitors, chemotherapy, or immunotherapy have shown promising synergistic effects.

Shatrudhan Prajapati, Shabana Khatoon, A. Singh et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.